122 related articles for article (PubMed ID: 30900418)
21. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
22. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
23. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.
Li J; Wei L
Biomed Pharmacother; 2019 Jan; 109():519-529. PubMed ID: 30399588
[TBL] [Abstract][Full Text] [Related]
25. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.
Bae KM; Wang H; Jiang G; Chen MG; Lu L; Xiao L
Cancer Res; 2007 Jul; 67(13):6053-63. PubMed ID: 17616661
[TBL] [Abstract][Full Text] [Related]
27. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of TRPV3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer.
Li X; Zhang Q; Fan K; Li B; Li H; Qi H; Guo J; Cao Y; Sun H
Int J Mol Sci; 2016 Mar; 17(4):437. PubMed ID: 27023518
[TBL] [Abstract][Full Text] [Related]
30. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
31. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
32. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
33. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.
Pahwa R; Dubhashi J; Singh A; Jailwala P; Lobanov A; Thomas CJ; Ceribelli M; Wilson K; Ricketts CJ; Vocke CD; Wells C; Bottaro DP; Linehan WM; Neckers L; Srinivasan R
J Exp Clin Cancer Res; 2022 Jun; 41(1):208. PubMed ID: 35754026
[TBL] [Abstract][Full Text] [Related]
36. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
[TBL] [Abstract][Full Text] [Related]
37. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
[TBL] [Abstract][Full Text] [Related]
38. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer.
Lo FY; Chen HT; Cheng HC; Hsu HS; Wang YC
Lung Cancer; 2012 Sep; 77(3):585-92. PubMed ID: 22749159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
